442 related articles for article (PubMed ID: 23109472)
1. Hemophilia and prophylaxis.
Ljung R
Pediatr Blood Cancer; 2013; 60 Suppl 1():S23-6. PubMed ID: 23109472
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic therapy in haemophilia.
Ljung R
Blood Rev; 2009 Nov; 23(6):267-74. PubMed ID: 19775786
[TBL] [Abstract][Full Text] [Related]
3. Importance of pharmacokinetics in the management of hemophilia.
Barnes C
Pediatr Blood Cancer; 2013; 60 Suppl 1():S27-9. PubMed ID: 23109436
[TBL] [Abstract][Full Text] [Related]
4. Prevention of haemophilic synovitis: prophylaxis.
Lee CA
Haemophilia; 2007 Nov; 13 Suppl 3():20-5. PubMed ID: 17822517
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.
Fischer K; Valentino L; Ljung R; Blanchette V
Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of joint damage in hemophilic children with early prophylaxis].
Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B
Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528
[TBL] [Abstract][Full Text] [Related]
7. Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens.
Berntorp E
Haemophilia; 2009 Nov; 15(6):1219-27. PubMed ID: 19659939
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis in children with hemophilia: is it the optimal treatment?
Lusher JM
Thromb Haemost; 1997 Jul; 78(1):726-9. PubMed ID: 9198246
[No Abstract] [Full Text] [Related]
9. A comparison of traditional vs. Canadian tailored prophylaxis dosing of prophylactic factor infusions in children with haemophilia A and B in a single hemophilia treatment center.
Dodd C; Watts RG
Haemophilia; 2012 Jul; 18(4):561-7. PubMed ID: 22221939
[TBL] [Abstract][Full Text] [Related]
10. Identifying and overcoming barriers to prophylaxis in the management of haemophilia.
Petrini P
Haemophilia; 2007 Sep; 13 Suppl 2():16-22. PubMed ID: 17685919
[TBL] [Abstract][Full Text] [Related]
11. Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China.
Wu R; Luke KH; Poon MC; Wu X; Zhang N; Zhao L; Su Y; Zhang J
Haemophilia; 2011 Jan; 17(1):70-4. PubMed ID: 20579111
[TBL] [Abstract][Full Text] [Related]
12. Orthopaedic evaluation in children with severe haemophilia A or B submitted to primary prophylaxis therapy in a coagulopathy treatment centre.
De Podestá Haje D; Ono F; De Oliveira GB; Almeida J; De Paula JC; Batista Neto LV; Silva Barros SB
Haemophilia; 2011 Mar; 17(2):228-32. PubMed ID: 21070500
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis for severe haemophilia: clinical and economical issues.
Fischer K; Van Den Berg M
Haemophilia; 2003 Jul; 9(4):376-81. PubMed ID: 12828671
[TBL] [Abstract][Full Text] [Related]
14. The overall effectiveness of prophylaxis in severe haemophilia.
Panicker J; Warrier I; Thomas R; Lusher JM
Haemophilia; 2003 May; 9(3):272-8. PubMed ID: 12694517
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome.
Fischer K; van der Bom JG; Molho P; Negrier C; Mauser-Bunschoten EP; Roosendaal G; De Kleijn P; Grobbee DE; van den Berg HM
Haemophilia; 2002 Nov; 8(6):745-52. PubMed ID: 12410642
[TBL] [Abstract][Full Text] [Related]
16. The role of prophylaxis in bleeding disorders.
Berntorp E; de Moerloose P; Ljung RC
Haemophilia; 2010 Jul; 16 Suppl 5():189-93. PubMed ID: 20590880
[TBL] [Abstract][Full Text] [Related]
17. Primary prophylaxis in children with haemophilia.
Coppola A; Di Capua M; De Simone C
Blood Transfus; 2008 Sep; 6 Suppl 2(Suppl 2):s4-11. PubMed ID: 19105503
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis in patients with haemophilia: introduction.
Chambost H
Haemophilia; 2010 Mar; 16 Suppl 2():1-3. PubMed ID: 20132331
[No Abstract] [Full Text] [Related]
19. Current issues in prophylactic therapy for persons with hemophilia.
Dunn AL; Abshire TC
Acta Haematol; 2006; 115(3-4):162-71. PubMed ID: 16549891
[TBL] [Abstract][Full Text] [Related]
20. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
